4
Changes in Ownership
GeneDx Holdings Corp. Filed Acc 0001944119-26-000006
CHIEF FINANCIAL OFFICER sold 317 shares at an average $93.99 ($29,794)
- CHIEF FINANCIAL OFFICER acquired 754 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Feeley Kevin · CHIEF FINANCIAL OFFICER
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-29 | Exercise or conversion : show line 1 in the form | +754 | 9,485 | D | ||
| 2026-01-29 | Sale : show line 2 in the form | −315 | $94.00 | $29,610 | 9,170 | D |
| 2026-01-29 | Sale : show line 3 in the form | −2 | $92.06 | $184 | 9,168 | D |
| Open-market sales · 317 sh · avg $93.99 · $29,794 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-29 | Exercise or conversion : show line 4 in the form Restricted Stock Unit | −754 | 754 | D |
Loading xslF345X05/form4-02022026_090237.xml…